Antibodies : Engineering and Therapeutics

Antibodies, also called immunoglobulins, are large Y-shaped proteins which function to identify and help remove foreign antigens or targets such as viruses and bacteria. Antibodies are produced by specialized white blood cells called B lymphocytes (or B cells). When an antigen binds to the B-cell surface, it stimulates the B cell to divide and mature into a group of identical cells called a clone. The mature B cells, called plasma cells, secrete millions of antibodies into the bloodstream and lymphatic system. Every different antibody recognizes a specific foreign antigen. This is because the two tips of its “Y” are specific to each antigen, allowing different antibodies to bind to different foreign antigens.Antibodies are produced by the immune system in response to the presence of an antigen. Antigens are large molecules, usually proteins, on the surface of cells, viruses, fungi, bacteria, and some non-living substances such as toxins, chemicals, and foreign particles. Any substance capable of triggering an immune response is called an antigen. The antibody recognizes a unique molecule of the harmful agent, called an antigen, via the variable region.

Antibody engineering has become a well-developed discipline, encompassing discovery methods, production strategies, and modification techniques that have brought forth clinically investigated and marketed therapeutics. The realization of the long-standing goal of production of fully human monoclonal antibodies has focused intensive research on the clinical employment of this potent drug category.

  • Lymphocytes: Research and novel strategies
  • Genomic, metabolomic and proteomic advances in cancer immunotherapy
  • Genetics and epigenetics of the immune system
  • Antibody-targeted fusion proteins for cancer therapy
  • Antibodies as drugs: Immunological scaffolds as therapeutics
  • Antibody biology & engineering
  • Antibodies and infectious diseases
  • Monoclonal antibodies and organ cancers
  • Antibodies and neuroscience
  • Genomic, metabolomic and proteomic advances in cancer immunotherapy

Related Conference of Antibodies : Engineering and Therapeutics

June 28-30 2020

BIOENERGY MEET 2020

June 23-24, 2020

34th World Congress on Vaccines and Immunization

Osaka, Japan
June 25-26, 2020

Global Congress on Asthma, Allergy and Immunology

Bali, Indonesia
July 15-16, 2020

35th World Congress on Immunology

London, UK
September 16-17, 2020

8th World Summit on Allergy and Clinical Immunology

Barcelona, Spain
October 12-13, 2020

International Conference on Vaccine and Vaccine Research

Manila, Philippines
October 12-13, 2020

4th International Conference on Mass Spectrometry

Milan, Italy
October 14-15, 2020

13th International Conference on Allergy & Immunology

Zurich, Switzerland
October 19-20, 2020

2nd World Conference on Vaccine and Immunology

Helsinki, Finland
October 26-27, 2020

12th Global Summit on Immunology and Cell Biology

Amsterdam, Netherlands
October 26-27, 2020

10th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa
October 28-29, 2020

12th Annual Conference on Clinical Immunology

Dubai, UAE
October 29-30, 2020

International Conference on HIV and AIDS

Cape Town, South Africa
November 2-3, 2020

International Conference on Immunology

Rome, Italy
November 05-06, 2020

4th Annual Summit on Rare Diseases and Orphan Drugs

Paris, France
November 18-19, 2020

International Conference on Immunology & Immunotherapies

Bangkok, Thailand
June 28-30 2020

veternarymedicine-2020

Antibodies : Engineering and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in